LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma - No Study Results Posted

LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma (ACDAL)

This study is ongoing, but not recruiting participants.

Study NCT00082225 Information provided by Baylor College of Medicine

First Received: May 3, 2004 Last Updated: July 15, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	April 2012
Primary Completion Date:	June 2011 (Final data collection date for primary outcome measure)